DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	251,014	191,632	164,306	164,657	163,255	269,902
Market Cap Growth	47.68%	16.63%	-0.21%	0.86%	-39.51%	21.16%
Enterprise Value	347,102	288,813	265,142	243,200	219,445	325,800
Last Close Price	14330.00	10902.01	9214.79	9080.87	8847.03	14454.43
PE Ratio	384.84	360.61	-	147.59	73.63	-
PS Ratio	1.69	1.28	1.16	1.25	1.39	2.47
PB Ratio	3.43	2.51	2.12	2.02	1.96	3.13
P/TBV Ratio	6.45	4.49	3.67	3.27	2.96	4.49
P/FCF Ratio	43.52	218.93	-	-	232.62	-
P/OCF Ratio	30.02	36.50	-	20.10	15.72	101.72
EV/Sales Ratio	2.34	1.93	1.88	1.84	1.87	2.98
EV/EBITDA Ratio	27.10	22.02	33.85	23.41	27.08	33.90
EV/EBIT Ratio	53.22	43.03	135.12	41.60	66.82	82.64
EV/FCF Ratio	60.18	329.96	-	-	312.68	-
Debt / Equity Ratio	1.34	1.30	1.43	1.10	0.84	0.74
Debt / EBITDA Ratio	7.67	7.57	14.11	8.67	8.66	6.61
Debt / FCF Ratio	17.03	113.42	-	-	99.96	-
Asset Turnover	0.71	0.70	0.68	0.70	0.67	0.64
Inventory Turnover	3.19	3.35	3.86	4.10	3.85	3.63
Quick Ratio	0.23	0.25	0.29	0.33	0.49	0.39
Current Ratio	0.49	0.52	0.51	0.62	0.75	0.66
Return on Equity (ROE)	1.05%	1.08%	-0.65%	1.48%	2.31%	-2.92%
Return on Assets (ROA)	1.96%	1.97%	0.59%	1.94%	1.17%	1.44%
Return on Capital (ROIC)	2.30%	2.31%	0.68%	2.25%	1.35%	1.73%
Return on Capital Employed (ROCE)	8.10%	7.60%	2.20%	5.00%	3.20%	4.00%
Earnings Yield	0.26%	0.28%	-0.70%	0.68%	1.36%	-0.74%
FCF Yield	2.30%	0.46%	-5.55%	-11.84%	0.43%	-0.41%
Dividend Yield	1.04%	1.38%	1.63%	1.65%	-	-
Payout Ratio	402.83%	494.43%	-	235.51%	118.28%	-
Buyback Yield / Dilution	0.12%	-	-	-0.33%	-0.87%	1.48%
Total Shareholder Return	1.16%	1.38%	1.63%	1.33%	-0.87%	1.48%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.